(Q33333731)

25 July 2017

A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomas (English)

1 reference

25 July 2017

phase II clinical trial

0 references

author

Bernd Walter Scheithauer

4

object named as

Scheithauer BW

1 reference

25 July 2017

Burch PA

1

1 reference

25 July 2017

Bernath AM

2

1 reference

25 July 2017

Cascino TL

3

1 reference

25 July 2017

Novotny P

5

1 reference

25 July 2017

Nair S

6

1 reference

25 July 2017

Buckner JC

7

1 reference

25 July 2017

Pfeifle DM

8

1 reference

25 July 2017

Kugler JW

9

1 reference

25 July 2017

Tschetter LK

10

1 reference

25 July 2017

1 August 2000

1 reference

Investigational New Drugs

25 July 2017

1 reference

25 July 2017

18

1 reference

25 July 2017

3

1 reference

25 July 2017

275-280

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1006438109266

25 July 2017

0 references

cites work

Lack of efficacy of 9-aminocamptothecin in adults with newly diagnosed glioblastoma multiforme and recurrent high-grade astrocytoma. NABTT CNS Consortium

1 reference

12 December 2020

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

12 December 2020

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

1 reference

12 December 2020

Treatment of central nervous system xenografts with camptothecins.

1 reference

12 December 2020

Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against pediatric and adult central nervous system tumor xenografts.

1 reference

12 December 2020

Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates

1 reference

12 December 2020

Growth inhibition of human cancer metastases by camptothecins in newly developed xenograft models

1 reference

12 December 2020

The accumulation of topotecan in 9L glioma and in brain parenchyma with and without dexamethasone administration.

1 reference

12 December 2020

Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants. NABTT CNS Consortium. The New Approaches to Brain Tumor Therapy.

1 reference

12 December 2020

Radiation therapy in the management of low-grade supratentorial astrocytomas.

1 reference

12 December 2020

1 reference

12 December 2020

Phase II study of topotecan in patients with recurrent malignant glioma. National Clinical Institute of Canada Clinical Trials Group

1 reference

12 December 2020

Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors

1 reference

12 December 2020

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

12 December 2020

Irinotecan therapy in adults with recurrent or progressive malignant glioma.

1 reference

12 December 2020

The current status of camptothecin analogues as antitumor agents

1 reference

12 December 2020

Clinical pharmacodynamics of continuous infusion topotecan in children: systemic exposure predicts hematologic toxicity

1 reference

12 December 2020

A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844.

1 reference

12 December 2020

Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor

1 reference

12 December 2020

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Stud

1 reference

12 December 2020

Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.

1 reference

12 December 2020

Topotecan treatment of adults with primary malignant glioma. The Brain Tumor Center at Duke.

1 reference

12 December 2020

Phase II evaluation of topotecan for pediatric central nervous system tumors.

1 reference

12 December 2020

Camptothecins: from bench research to hospital wards.

1 reference

12 December 2020

Chemotherapy for malignant brain tumors

1 reference

12 December 2020

Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1006438109266

1 reference

Dimensions Publication ID

25 July 2017

0 references

1 reference